Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNMT1 | P26358 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | HTT | P42858 | 2/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | STAT3 | P40763 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | APAF1 | O14727 | 2/20 | 0.32 |
| ▸ | TDP2 | O95551 | 2/20 | 0.32 |
| ▸ | NSD2 | O96028 | 2/20 | 0.32 |
| ▸ | HKDC1 | Q2TB90 | 2/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Triaziquone SCHEMBL6272818 | 0.88 | DNMT1 (0.39) | DNMT1MAPTHTTSMN1; SMN2APAF1 | |
| Triaziquone SCHEMBL895712 | 0.88 | DNMT1 (0.43) | DNMT1MAPTHTTTP53STAT3 | |
| Triaziquone SCHEMBL22361758 | 0.87 | MAPT (0.39) | DNMT1MAPTHTTTP53STAT3 | |
| Triaziquone SCHEMBL9791390 | 0.86 | DNMT1 (0.42) | DNMT1MAPTHTTTP53STAT3 | |
| Triaziquone SCHEMBL17698632 | 0.85 | HTT (0.38) | DNMT1MAPTHTTTP53STAT3 | |
| Triaziquone SCHEMBL19715926 | 0.85 | DNMT1 (0.37) | DNMT1MAPTHTTTP53STAT3 | |
| Triaziquone SCHEMBL108508 | 0.84 | DNMT1 (0.41) | DNMT1MAPTHTTTP53STAT3 | |
| Triaziquone SCHEMBL8303 | 0.84 | DNMT1 (0.48) | DNMT1MAPTHTTTP53STAT3 | |
| Triaziquone SCHEMBL1462397 | 0.83 | DNMT1 (0.38) | DNMT1MAPTHTTTP53STAT3 | |
| Triaziquone SCHEMBL15269829 | 0.82 | DNMT1 (0.37) | DNMT1MAPTHTTTP53STAT3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 77 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3911657-A1 | PROCESS FOR CONVERTING ORGANOSILANES | Wacker Chemie AG (DE) | 2021-11-24 | — | — | EP | claimed |
| CN-107207404-B | Compound, and separation method, synthesis method and application thereof | 北京北大维信生物科技有限公司 | 2021-07-13 | — | — | CN | claimed |
| CN-113004235-A | Stereoselective synthesis method of (Z) -3-alkenyl phthalide derivative | 中国医学科学院药物研究所 | 2021-06-22 | — | — | CN | claimed |
| WO-2021004648-A1 | PROCESS FOR CONVERTING ORGANOSILANES | WACKER CHEMIE AG (DE) | 2021-01-14 | — | — | WO | claimed |
| EP-1694628-B1 | PROCESS FOR THE MANUFACTURE OF TRIMETHYLHYDROQUINE DIALKANOATES | DSM IP ASSETS BV (NL) | 2011-08-31 | — | — | EP | claimed |
| US-20110144358-A1 | Process for the manufacture of trimethylhydroquinone dialkanoates | DSM IP ASSETS B.V. (NL) | 2011-06-16 | — | — | US | claimed |
| JP-2007516262-A | — | — | 2007-06-21 | — | — | JP | claimed |
| US-20070049762-A1 | Process for the manufacture of trimethylydroquine dialkanoates | DSM IP ASSETS B.V. (NL) | 2007-03-01 | — | — | US | claimed |
| EP-1694628-A1 | PROCESS FOR THE MANUFACTURE OF TRIMETHYLHYDROQUINE DIALKANOATES | DSMIP Assets B.V. (NL) | 2006-08-30 | — | — | EP | claimed |
| WO-2005058792-A1 | PROCESS FOR THE MANUFACTURE OF TRIMETHYLHYDROQUINE DIALKANOATES | DSM IP ASSETS B.V. (NL) | 2005-06-30 | — | — | WO | claimed |
| CN-113454094-B | Method for converting organosilanes | 瓦克化学股份公司 | 2024-03-22 | — | — | CN | disclosed |
| CN-117561623-A | Secondary battery, manufacturing method thereof, battery module, battery pack and power utilization device | 宁德时代新能源科技股份有限公司 | 2024-02-13 | — | — | CN | disclosed |
| CN-116273169-A | Supported catalyst and preparation method thereof | 安庆莱霆光电科技有限公司 | 2023-06-23 | — | — | CN | disclosed |
| CN-116283520-A | Preparation method of aryl ketone, alpha-hydroxy ketone and alpha-amino ketone | 安庆莱霆光电科技有限公司 | 2023-06-23 | — | — | CN | disclosed |
| CN-113004235-B | Stereoselective synthesis method of (Z) -3-alkenylphthalide derivative | 中国医学科学院药物研究所 | 2023-05-05 | — | — | CN | disclosed |
| US-20020172885-A1 | Novel carbazole derivative and chemically amplified radiation-sensitive resin composition | JSR CORPORATION (JP) | 2002-11-21 | — | — | US | disclosed |
| EP-1238972-A1 | Novel carbazole derivative and chemically amplified radiation-sensitive resin composition | JSR Corporation (JP) | 2002-09-11 | — | — | EP | disclosed |
| US-20010041769-A1 | Polysiloxane, method of manufacturing same, silicon-containingalicyclic compouns, and radiation-sensitive resin composition | JSR CORPORATION (JP) | 2001-11-15 | — | — | US | disclosed |
| EP-1142928-A1 | Polysiloxane, method of manufacturing same, silicon-containing alicyclic compound, and radiation-sensitive resin compounds | JSR Corporation (JP) | 2001-10-10 | — | — | EP | disclosed |
| CN-1227556-A | Process for preparation of hexanitrohexaazaiso wurtzitanes | ASAHI CHEMICAL IND (JP) | 1999-09-01 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020172885-A1 | Novel carbazole derivative and chemically amplified radiation-sensitive resin composition | ARID2, RAD1, RAD51 | DNMT1 369/4885MAPT 3939/4885HTT 3475/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.